Xiu Jin
State Key Laboratory Of Biotherapy And Cancer Center
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Lipid Nanoparticle-Delivered mRNA Therapy Corrects Neonatal Murine MPS I-H.
Journal: Human gene therapy
Published: March 26, 2026
RP1 Dual-AAV Gene Therapy Preserves Retinal Structure and Ameliorates Photoreceptor Degeneration in a Murine Model of Retinitis Pigmentosa.
Journal: Investigative ophthalmology & visual science
Published: September 12, 2025
Rescue of neurologic disease in mucopolysaccharidosis type II mice via AAV-mediated liver delivery of brain-penetrating iduronate-2-sulfatase.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 04, 2025
Comparative evaluation of liver-directed knockin strategies with viral and nonviral vectors in mouse inherited disease models.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 29, 2025
AAV-delivered engineered suppressor tRNA rescues visual function in mice with an inherited retinal disease.
Journal: Nature communications
Published: April 02, 2025
Split AAV8 Mediated ABCA4 Expression for Gene Therapy of Mouse Stargardt Disease (STGD1).
Journal: Human gene therapy
Published: May 25, 2023
In vivo adenine base editing corrects newborn murine model of Hurler syndrome.
Journal: Molecular biomedicine
Published: December 12, 2022
In vivo base editing rescues photoreceptors in a mouse model of retinitis pigmentosa.
Journal: Molecular therapy. Nucleic acids
Published: June 22, 2022
Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration.
Journal: Signal transduction and targeted therapy
Published: June 09, 2022
Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler.
Journal: Molecular therapy. Methods & clinical development
Published: December 15, 2021
Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration.
Journal: Molecular therapy. Methods & clinical development
Published: August 02, 2021
In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system.
Journal: Molecular therapy. Methods & clinical development
Published: July 28, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026